Intrinsic Value

Is NZM2 undervalued or overvalued?

See the intrinsic value estimate for Novozymes A/S and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

NZM2 Intrinsic Value
LOCKED
Unlock
Today vs. history

NZM2 looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with NZM2’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor NZM2
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price €59.12
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to NZM2

Fundamental Analysis

What Novozymes A/S Does

Chemicals Materials

Novozymes A/S, a beacon of innovation in biotechnology, operates at the intricate intersection of science and sustainability. Born from the storied roots of Novo Nordisk in 2000, this Danish company has carved out a niche in the enzyme and microbial sector. Novozymes’ core competency lies in its ability to harness the power of natural organisms, using them to drive forward industrial solutions that are not only efficient but also eco-friendly.

Headquarters
Denmark DK
Employees
6 184
IPO date
May 27, 1905
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Novozymes A/S

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one NZM2 stock?

The intrinsic value for Novozymes A/S (NZM2) under the Base Case is hidden EUR.

Is NZM2 stock undervalued or overvalued?

Compared with the current market price of 59.12 EUR, the stock appears hidden.

Back to Top